⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 27, 2014Pharmacogenetics and GenomicsOpen Access

PharmGKB summary

Maria L. Alvarellos Jatinder K. Lamba Katrin Sangkuhl Caroline F. Thorn Liewei Wang Daniel J. Klein Russ B. Altman Teri E. Klein

View Full Paper

Ask AI

Bookmark

Share

Abstract

Alvarellos, Maria L.; Lamba, Jatinder; Sangkuhl, Katrin; Thorn, Caroline F.; Wang, Liewei; Klein, Daniel J.; Altman, Russ B.; Klein, Teri E.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alvarellos et al. (2014) studied this question.

synapsesocial.com/papers/6a70f1cbfebe604dd709b353 https://doi.org/10.1097/fpc.0000000000000086

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical pharmacology and pharmacogenetics of gemcitabineReview · 2009 · 156 citations
2Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based ChemotherapiesOriginal Research · 2009 · 128 citations
3Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cellsOriginal Research · 2012 · 16 citations
4Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissueOriginal Research · 2012 · 18 citations
5Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialOriginal Research · 2013 · 337 citations

More related papers

The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma2004
CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells2011
Effect of Genetic Polymorphisms on Therapeutic Response and Clinical Outcomes in Pancreatic Cancer Patients Treated with Gemcitabine2012

More from Pharmacogenetics and Genomics

Distribution of the J1 haplotype variant rs2267439 across CYP2D6 diplotypes and its impact on risperidone metabolismWed,
Genetic variation in SLCO1B1 is associated with methotrexate intolerance symptoms in juvenile idiopathic arthritis patientsTue,